Share this project

Done

Share this project

Done
PSYCHEDELIA: A Documentary project video thumbnail
Replay with sound
Play with
sound

The story of the most powerful mind-altering substances known to mankind. Read more

New York, NY Documentary
Share this project
48
backers
$3,706
pledged of $7,500 goal
0
seconds to go

Funding Unsuccessful

This project's funding goal was not reached on June 16, 2013.

The story of the most powerful mind-altering substances known to mankind.

New York, NY Documentary
Share this project

About this project

OVERVIEW OF THE PROJECT:

PSYCHEDELIA is a documentary about the rich and complex history of psychedelic drugs in human society. It explores their origin among tribal peoples and ancient mystics, their influence on the counterculture of the 1960s, and their recent reemergence in medical studies at major Universities in the United States.

The film is FINISHED, but I lack sufficient funds to license old photographs, films, and music so that I can legally screen the film to audiences. This money would allow me to share this important story with public audiences. 

BACKGROUND ON THE PROJECT:

I started this project as a senior at NYU Tisch School of the Arts after learning about a study at NYU School of Medicine exploring the use of psilocybin, the active ingredient in magic mushrooms, to treat end-of-life anxiety in cancer patients. After learning more about the study and psychedelics in general, I uncovered a history that I had not previously known. I felt that it was important to convey the historical background of these agents in order to give context to the current studies. 

WHY I NEED YOUR HELP:

Copyright laws in the United States forbid me from showing this film to public audiences due to unlicensed copyrighted material in the film. Knowing this ahead of time, I searched for material in the National Archives and public domain, but not everything fell into those categories. I have contacted publishers for estimates on the costs and have based my goal on those numbers. 

SUMMARY OF THE STORY:

Since before recorded history, mankind has sought ways to expand consciousness and answer the great mysteries of existence. Researchers have traced evidence of psychedelic plant use in shamanic, religious, and spiritual contexts throughout cultures around the world. Among other things, they have been used to prepare for war, to locate lost people, and to glimpse into unseen spiritual realms.

In the late 1950s, J.P. Morgan Vice President R. Gordon Wasson traveled to a remote village in Mexico to participate in an ancient mushroom ritual. He published his profound experience in Life Magazine, helping spread the word to Western civilization. Among those influenced by his writing was Harvard psychologist Timothy Leary. 

After the discovery of LSD in the 1940s, Sandoz Pharmaceuticals distributed the drug to researchers and psychiatrists around the world. Therapists found that under the right conditions, LSD produced a mystical experience, leading to promising therapeutic outcomes for a variety of conditions including chronic alcoholism. Many of these conditions had proven impervious to conventional methods.

Due in good part to the proselytizing efforts of Timothy Leary, LSD escaped the laboratory and became entwined with the protest movements and cultural explosion of the 1960s. Partly because of headline-grabbing suicide attempts, and partly as an attempt to stamp-out cultural upheaval, psychedelics were placed under tight control by the Controlled Substance Act of 1970. Research faded out and the agents largely vanished from our culture. 

During the 1990s, Rick Strassman broke the seal with a research study exploring the psycho-spiritual effects of DMT. This helped pave the way for research using psilocybin at Johns Hopkins, UCLA, and NYU. These studies have used psilocybin to treat anxiety for individuals with terminal illness. They have shown promise in reducing end-of-life psycho-spiritual distress. 

PEOPLE IN THE FILM:

PSYCHEDELIA features a number of interviewees prominent in the field of psychedelic research. Some led pre-1970 studies while others are involved in current research. In addition the film features a participant in the NYU Psilocybin Cancer Anxiety Study. 

Dr. Herbert Kleber

Former Medical Director & Vice President, National Center on Addiction and Substance Abuse at Columbia University; former deputy director, Office of National Drug Control Policy; and Professor of Psychiatry, Columbia University
Former Medical Director & Vice President, National Center on Addiction and Substance Abuse at Columbia University; former deputy director, Office of National Drug Control Policy; and Professor of Psychiatry, Columbia University

Charles S. Grob, M.D.

Professor of Psychiatry at UCLA, Director of Psilocybin Cancer Anxiety study, Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center
Professor of Psychiatry at UCLA, Director of Psilocybin Cancer Anxiety study, Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center

Dr. Stephen Ross

Principal Investigator, NYU Psilocybin Cancer Anxiety Study; Director, Division of Alcoholism & Drug Abuse, Bellevue Hospital; Director, NYU Addiction Psychiatry Fellowship
Principal Investigator, NYU Psilocybin Cancer Anxiety Study; Director, Division of Alcoholism & Drug Abuse, Bellevue Hospital; Director, NYU Addiction Psychiatry Fellowship

Jeffrey Guss, M.D.

Co-Principal Investigator, NYU Psilocybin Cancer Anxiety Study; Clinical Assistant Professor of Psychiatry at New York University School of Medicine; Senior Faculty member of the Division of Alcohol and Drug Abuse in NYU’s Department of Psychiatry
Co-Principal Investigator, NYU Psilocybin Cancer Anxiety Study; Clinical Assistant Professor of Psychiatry at New York University School of Medicine; Senior Faculty member of the Division of Alcohol and Drug Abuse in NYU’s Department of Psychiatry

Anthony Bossis, Ph.D.

Co-Principal Investigator and Director Palliative Care Research, NYU Cancer Anxiety Psilocybin Research Clinical Assistant Professor of Psychiatry, NYU School of Medicine
Co-Principal Investigator and Director Palliative Care Research, NYU Cancer Anxiety Psilocybin Research Clinical Assistant Professor of Psychiatry, NYU School of Medicine

Matthew Johnson, Ph.D.

Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine; Matthew has been involved in various psychedelic studies at Johns Hopkins
Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine; Matthew has been involved in various psychedelic studies at Johns Hopkins

Neal Goldsmith, Ph.D.

Psychotherapist in New York City specializing in psychospiritual development and resistance to change; Author of "Psychedelic Healing"
Psychotherapist in New York City specializing in psychospiritual development and resistance to change; Author of "Psychedelic Healing"

Ingmar Gorman

Completing his MA in Pyschology at The New School; Has been studying psychedelic-assisted psychotherapy since 2005; conducted a research study looking back on decades of LSD research in Czechoslovakia
Completing his MA in Pyschology at The New School; Has been studying psychedelic-assisted psychotherapy since 2005; conducted a research study looking back on decades of LSD research in Czechoslovakia

Robert Cohen

Professor of history and social studies in NYU’s Steinhardt School of Culture, Education, and Human Development; His historical scholarship  focuses on politics, higher education, and social protest in twentieth century America
Professor of history and social studies in NYU’s Steinhardt School of Culture, Education, and Human Development; His historical scholarship focuses on politics, higher education, and social protest in twentieth century America

Estalyn Walcoff 

Psychotherapist and former patient of the NYU Psilocybin Study
Psychotherapist and former patient of the NYU Psilocybin Study

Risks and challenges

Making a film, especially independently, is a challenging endeavor. There is a lot of work required by the various stages. Pre-production, finding your story and developing a strategy to make the product. Production, searching for and traveling to various interview subjects, shooting b-roll footage, and climbing mountaintops in time to catch the sunset. Post-production, taking hours and hours of footage and seemingly endless intellectual tangents and turning it into a cohesive story.

After all that is done, you have to make sure you are legally permitted to show the film to audiences, as documentaries, and especially this one, use a lot of copyrighted material. And even though it's for purely editorial purposes, it costs money.

I feel prepared to take on the task of securing licenses for all of the material. If a piece of music or archival video is out of the question in terms of costs, I feel comfortable enough that I can find ways creatively to work around it. I have contacted most of the holders of the copyright and have gotten estimates so my goal is based on real numbers.

By working in the documentary industry and being a graduate of NYU Tisch I also have a number of different advisors I can ask questions. They are people who have been doing this for many years.

Learn about accountability on Kickstarter

FAQ

Have a question? If the info above doesn't help, you can ask the project creator directly.

Ask a question

Rewards

  1. Select this reward

    Pledge $10 or more
    About $10 USD

    2 backers

    A sincere THANK YOU for your interest and your help in this endeavor.

    Less
    Estimated delivery:
    Manage your pledge
  2. Select this reward

    Pledge $25 or more
    About $25 USD

    16 backers

    A DIGITAL DOWNLOAD of the film upon completion, PLUS THE ABOVE.

    Less
    Estimated delivery:
    Manage your pledge
  3. Select this reward

    Pledge $50 or more
    About $50 USD

    6 backers

    Access to the EXTENDED INTERVIEWS of a collection of psychedelic research experts, authors, and University professors, as well as the above.

    Less
    Estimated delivery:
    Manage your pledge
  4. Select this reward

    Pledge $100 or more
    About $100 USD

    12 backers

    SPECIAL THANKS credit at the end of the film well as the above.

    Less
    Estimated delivery:
    Manage your pledge
  5. Select this reward

    Pledge $250 or more
    About $250 USD

    1 backer

    Invitation to a SCREENING OF THE FILM upon completion, along with all the above. Meet the filmmaker and some of the people involved in the production.

    Less
    Estimated delivery:
    Manage your pledge
  6. Select this reward

    Pledge $500 or more
    About $500 USD

    1 backer

    Receive a customized RESEARCH PACKAGE including extended scenes, archival documentary films, research papers, and resources for your own investigation into all things psychedelic... as well as the above.

    Less
    Estimated delivery:
    Manage your pledge
  7. Select this reward

    Pledge $1,000 or more
    About $1,000 USD

    0 backers

    Meet some of the people involved in psychedelic research. Attend a screening of the film and afterwards join the filmmaker and some of the interview subjects for a dinner out. And, of course, all the above.

    Less
    Estimated delivery:
    Manage your pledge

Funding period

- (30 days)